|
GS185131: GO:0044699 single-organism process
|
|
GS198194: GO:0034702 ion channel complex
|
|
GS192507: GO:0006812 cation transport
|
|
GS170929: HP:0001285 Spastic tetraparesis
|
|
GS204008: GO:0008076 voltage-gated potassium channel complex
|
|
GS201107: GO:0005249 voltage-gated potassium channel activity
|
|
GS189451: GO:0034765 regulation of ion transmembrane transport
|
|
GS36049: Neocortex Gene expression correlates of Light- Dark Box Total seconds spent in light compartment in Females & Males BXD
|
|
GS136888: voluntary alcohol consumption QTL 1 (Vacq1, Published QTL Chr 2)
|
|
GS202940: GO:0006935 chemotaxis
|
|
GS36077: Striatum Gene expression correlates of Activity in altered context in fear conditioning apparatus in Females & Males BXD
|
|
GS195083: GO:0007267 cell-cell signaling
|
|
GS176385: HP:0001249 Intellectual disability
|
|
GS167898: MP:0009357 abnormal seizure response to inducing agent
|
|
GS170021: MP:0011087 complete neonatal lethality
|
|
GS165643: MP:0011088 partial neonatal lethality
|
|
GS181423: GO:0022891 substrate-specific transmembrane transporter activity
|
|
GS184299: GO:0005249 voltage-gated potassium channel activity
|
|
GS165874: MP:0002133 abnormal respiratory system physiology
|
|
GS170024: MP:0011086 partial postnatal lethality
|
|
GS192508: GO:0006811 ion transport
|
|
GS183543: GO:0051179 localization
|
|
GS205500: GO:0071944 cell periphery
|
|
GS197017: GO:0032990 cell part morphogenesis
|
|
GS36163: Neocortex Gene expression correlates of Locomotor response of 10 mg/kg MDMA injected on Day 2 in Males BXD
|
|
GS84143: alcohol consumption (Published QTL, Chr 2)
|
|
GS166617: MP:0003412 abnormal afterhyperpolarization
|
|
GS196169: GO:0005216 ion channel activity
|
|
GS124438: Astemizole interacting genes (MeSH:D016589) in CTD
|
|
GS175448: HP:0007359 Focal seizures
|
|
GS192671: GO:0055085 transmembrane transport
|
|
GS195226: GO:0015075 ion transmembrane transporter activity
|
|
GS196080: GO:0040011 locomotion
|
|
GS176591: HP:0001276 Hypertonia
|
|
GS179401: GO:0005215 transporter activity
|
|
GS194234: GO:0033267 axon part
|
|
GS175390: HP:0011007 Age of onset
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS35071: Whole Brain Gene expression correlates of Difference in time on rotarod between saline and ethanol in Females & Males BXD
|
|
GS198782: GO:0044459 plasma membrane part
|
|
GS205439: GO:0031175 neuron projection development
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS203406: GO:0009653 anatomical structure morphogenesis
|
|
GS177870: GO:0008092 cytoskeletal protein binding
|
|
GS34243: Neocortex Gene expression correlates of Light-Dark Box Percentage time in light in Males BXD
|
|
GS179009: GO:0015672 monovalent inorganic cation transport
|
|
GS184448: GO:0044425 membrane part
|
|
GS198213: GO:0022890 inorganic cation transmembrane transporter activity
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS209525: GO:0032989 cellular component morphogenesis
|
|
GS200341: GO:0051179 localization
|
|
GS183767: GO:0019725 cellular homeostasis
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS195082: GO:0007268 synaptic transmission
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS121903: N-(1-(4-cyclopropylmethyl-3,4-dihydro-2H-benzo(1,4)oxazin-6-yl)ethyl)-3-(2-fluorophenyl)acrylamide interacting genes (MeSH:C492891) in CTD
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS205816: GO:0022839 ion gated channel activity
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS136714: susceptibility to lung cancer 17 (Sluc17, Published QTL Chr 2)
|
|
GS181473: GO:0005488 binding
|
|
GS36029: Neocortex Gene expression correlates of Light-Dark Box Total seconds spent in dark compartment in Males BXD
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS87054: Table S2: List of probe-sets of genes differentially expressed among the four inbred strains of mice. DBA/2J [DRG]
provisional
|
|
GS173263: HP:0003623 Neonatal onset
|
|
GS173246: HP:0001332 Dystonia
|
|
GS194235: GO:0033268 node of Ranvier
|
|
GS207616: GO:0016020 membrane
|
|
GS182559: GO:0005261 cation channel activity
|
|
GS173144: HP:0002411 Myokymia
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS198004: GO:0007399 nervous system development
|
|
GS185880: GO:0035637 multicellular organismal signaling
|
|
GS136842: telomere length QTL 1 (Tlq1, Published QTL Chr 2)
|
|
GS202125: GO:0030424 axon
|
|
GS164264: MP:0002082 postnatal lethality
|
|
GS135311: autoimmune ovarian dysgenesis 4 (Aod4, Published QTL Chr 2)
|
|
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
|
|
GS185024: GO:0044463 cell projection part
|
|
GS193991: GO:0048731 system development
|
|
GS125137: N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide interacting genes (MeSH:C476437) in CTD
|
|
GS135575: cystic fibrosis lung disease 1 (Cfld1, Published QTL Chr 2)
|
|
GS172258: HP:0002197 Generalized seizures
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS186067: GO:0050877 neurological system process
|
|
GS175529: HP:0000001 All
|
|
GS84140: alcohol consumption (Published QTL, Chr 2)
|
|
GS193018: GO:0003008 system process
|
|
GS175527: HP:0000006 Autosomal dominant inheritance
|
|
GS201839: GO:0044463 cell projection part
|
|
GS200620: GO:0022843 voltage-gated cation channel activity
|
|
GS178812: GO:0015267 channel activity
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS124038: Histamine interacting genes (MeSH:D006632) in CTD
|
|
GS33974: Cerebellum Gene expression correlates of Morphine distance (cm) travelled minutes 15-30 in Females & Males BXD
|
|
GS193288: GO:0015079 potassium ion transmembrane transporter activity
|
|
GS179671: GO:0030001 metal ion transport
|
|
GS188954: GO:0022838 substrate-specific channel activity
|
|
GS208012: GO:0044464 cell part
|
|
GS181424: GO:0022890 inorganic cation transmembrane transporter activity
|
|
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
|
|
GS201252: GO:0044425 membrane part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS84137: high-dose ethanol actions (Published QTL, Chr 2)
|
|
GS180083: GO:0034220 ion transmembrane transport
|
|
GS209451: GO:0006811 ion transport
|
|
GS181532: GO:0046873 metal ion transmembrane transporter activity
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS164261: MP:0002081 perinatal lethality
|
|
GS178478: GO:0015077 monovalent inorganic cation transmembrane transporter activity
|
|
GS135808: erosive arthritis susceptibility 1 (Erars1, Published QTL Chr 2)
|
|
GS135915: gestational survival modifier locus (Gstml, Published QTL Chr 2)
|
|
GS186190: GO:0043194 axon initial segment
|
|
GS205144: GO:0048468 cell development
|
|
GS192789: GO:0008324 cation transmembrane transporter activity
|
|
GS190899: GO:0043005 neuron projection
|
|
GS33904: Cerebellum Gene expression correlates of Distance traveled (cm) during the third five minute bin after ethanol in Females BXD
|
|
GS168088: MP:0011110 partial preweaning lethality
|
|
GS34630: Whole Brain Gene expression correlates of Novel environment distance (cm) travelled min 15-30 in BXD Males
|
|
GS191568: GO:0030506 ankyrin binding
|
|
GS196432: GO:0030001 metal ion transport
|
|
GS36778: Cerebellum Gene expression correlates of Zero Maze - Percentage open time in Males BXD
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS188042: GO:0060081 membrane hyperpolarization
|
|
GS204425: GO:0048812 neuron projection morphogenesis
|
|
GS126147: caffeic acid phenethyl ester interacting genes (MeSH:C055494) in CTD
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS188949: GO:0022836 gated channel activity
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS198193: GO:0034705 potassium channel complex
|
|
GS135927: hepatocarcinogenesis susceptibility 4 (Hcs4, Published QTL Chr 2)
|
|
GS164263: MP:0002083 premature death
|
|
GS181425: GO:0022892 substrate-specific transporter activity
|
|
GS182834: GO:0005623 cell
|
|
GS176167: HP:0001257 Spasticity
|
|
GS122047: Ethylnitrosourea interacting genes (MeSH:D005038) in CTD
|
|
GS199201: GO:0031224 intrinsic to membrane
|
|
GS196002: GO:0048699 generation of neurons
|
|
GS208500: GO:0030506 ankyrin binding
|
|
GS35466: Cerebellum Gene expression correlates of Difference in total distance traveled (cm) (saline-ethanol) in Males BXD
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS205817: GO:0022838 substrate-specific channel activity
|
|
GS168012: MP:0010832 lethality during fetal growth through weaning
|
|
GS168013: MP:0010831 partial lethality
|
|
GS178314: GO:0044304 main axon
|
|
GS181406: GO:0034703 cation channel complex
|
|
GS185304: GO:0030424 axon
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS187146: GO:0044700 single organism signaling
|
|
GS121437: Fluorouracil interacting genes (MeSH:D005472) in CTD
|
|
GS162819: MP:0002906 increased susceptibility to pharmacologically induced seizures
|
|
GS136132: lithogenic gene 12 (Lith12, Published QTL Chr 2)
|
|
GS196941: GO:0008150 biological_process
|
|
GS198212: GO:0022891 substrate-specific transmembrane transporter activity
|
|
GS209449: GO:0006813 potassium ion transport
|
|
GS171948: HP:0002266 Focal clonic seizures
|
|
GS199634: GO:0005623 cell
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS167357: MP:0002206 abnormal CNS synaptic transmission
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS175539: HP:0007256 Abnormality of pyramidal motor function
|
|
GS209735: GO:0008324 cation transmembrane transporter activity
|
|
GS36094: Neocortex Gene expression correlates of Baseline activity in fear conditioning apparatus in Females & Males BXD
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS201431: GO:0005515 protein binding
|
|
GS188663: GO:0043269 regulation of ion transport
|
|
GS177347: GO:0042391 regulation of membrane potential
|
|
GS184506: GO:0006873 cellular ion homeostasis
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS195063: GO:0044304 main axon
|
|
GS135984: hematocrit QTL 2 (Hemq2, Published QTL Chr 2)
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS167541: MP:0009142 decreased prepulse inhibition
|
|
GS199267: GO:0043234 protein complex
|
|
GS199357: GO:0005261 cation channel activity
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS167796: MP:0008770 decreased survivor rate
|
|
GS195569: GO:0015267 channel activity
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS122772: N-(1-(4-fluoro-3-morpholin-4-ylphenyl)ethyl)-3-(4-fluorophenyl)acrylamide interacting genes (MeSH:C477185) in CTD
|
|
GS204095: GO:0030182 neuron differentiation
|
|
GS34932: Striatum Gene expression correlates of Open Field - Total distance traveled 10-15 minutes [Basal Behavior] in Males BXD
|
|
GS209452: GO:0006810 transport
|
|
GS184303: GO:0005244 voltage-gated ion channel activity
|
|
GS204608: GO:0019226 transmission of nerve impulse
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS184629: GO:0005515 protein binding
|
|
GS34212: Striatum Gene expression correlates of Light Dark Box Total distance traveled in dark compartment in Females & Males BXD
|
|
GS36019: Neocortex Gene expression correlates of Light-Dark Box Total seconds spent in dark compartment in Females & Males BXD
|
|
GS210236: GO:0000904 cell morphogenesis involved in differentiation
|
|
GS36059: Neocortex Gene expression correlates of Light- Dark Box Total seconds spent in light compartment in Males BXD
|
|
GS194459: GO:0051234 establishment of localization
|
|
GS179211: GO:0007154 cell communication
|
|
GS180152: GO:0065007 biological regulation
|
|
GS167915: MP:0000950 abnormal seizure response to pharmacological agent
|
|
GS164032: MP:0004811 abnormal neuron physiology
|
|
GS165397: MP:0001265 decreased body size
|
|
GS36134: Neocortex Gene expression correlates of Activity during 1st tone shock pairing in Males BXD
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS202899: GO:0050877 neurological system process
|
|
GS186078: GO:0022803 passive transmembrane transporter activity
|
|
GS209568: GO:0048666 neuron development
|
|
GS169836: MP:0005388 respiratory system phenotype
|
|
GS36087: Striatum Gene expression correlates of Activity in altered context in fear conditioning apparatus in Males BXD
|
|
GS136885: urinary albuminuria 1 (Ua1, Published QTL Chr 2)
|
|
GS196806: GO:0032502 developmental process
|
|
GS208126: GO:0009605 response to external stimulus
|
|
GS136162: leishmaniasis resistance 16 (Lmr16, Published QTL Chr 2)
|
|
GS135439: bone mineral density 6 (Bmd6, Published QTL Chr 2)
|
|
GS202795: GO:0007409 axonogenesis
|
|
GS170567: MP:0003997 tonic-clonic seizures
|
|
GS181988: GO:0044459 plasma membrane part
|
|
GS205810: GO:0022832 voltage-gated channel activity
|
|
GS209960: GO:0003008 system process
|
|
GS188953: GO:0022839 ion gated channel activity
|
|
GS166531: MP:0009745 abnormal behavioral response to xenobiotic
|
|
GS201060: GO:0042330 taxis
|
|
GS182404: GO:0031224 intrinsic to membrane
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS194087: GO:0003674 molecular_function
|
|
GS202908: GO:0022803 passive transmembrane transporter activity
|
|
GS185176: GO:0005267 potassium channel activity
|
|
GS177356: GO:0003674 molecular_function
|
|
GS207615: GO:0016021 integral to membrane
|
|
GS35472: Striatum Gene expression correlates of Left adrenal weight in Females BXD
|
|
GS176610: HP:0003593 Infantile onset
|
|
GS135442: bone marrow graft rejection 3 (Bmgr3, Published QTL Chr 2)
|
|
GS182402: GO:0031226 intrinsic to plasma membrane
|
|
GS208058: GO:0007411 axon guidance
|
|
GS182964: GO:0047485 protein N-terminus binding
|
|
GS176806: HP:0003812 Phenotypic variability
|
|
GS87137: Table S2: List of probe-sets of genes differentially expressed among the four inbred strains of mice. Gene Ranks [DRG]
provisional
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS178474: GO:0015075 ion transmembrane transporter activity
|
|
GS197610: GO:0022857 transmembrane transporter activity
|
|
GS136192: learning-contextual 10 (Lrnx10, Published QTL Chr 2)
|
|
GS169443: MP:0003088 abnormal prepulse inhibition
|
|
GS192509: GO:0006810 transport
|
|
GS198195: GO:0034703 cation channel complex
|
|
GS84139: nicotine sensitivity (Published QTL, Chr 2)
|
|
GS197008: GO:0005887 integral to plasma membrane
|
|
GS190714: GO:0016020 membrane
|
|
GS209450: GO:0006812 cation transport
|
|
GS135282: "alcohol preference locus 6, female specific" (Alcp6, Published QTL Chr 2)
|
|
GS185961: GO:0051049 regulation of transport
|
|
GS191552: GO:0042995 cell projection
|
|
GS176171: HP:0001250 Seizures
|
|
GS195214: GO:0009987 cellular process
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS196168: GO:0005215 transporter activity
|
|
GS177750: GO:0071805 potassium ion transmembrane transport
|
|
GS135903: granulosa cell tumorigenesis 8 (Gct8, Published QTL Chr 2)
|
|
GS180817: GO:0022857 transmembrane transporter activity
|
|
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG]
provisional
|
|
GS198322: GO:0046873 metal ion transmembrane transporter activity
|
|
GS198263: GO:0005488 binding
|
|
GS207805: GO:0043005 neuron projection
|
|
GS200809: GO:0030030 cell projection organization
|
|
GS189454: GO:0034762 regulation of transmembrane transport
|
|
GS136449: postnatal body weight growth 11 (Pbwg11, Published QTL Chr 2)
|
|
GS172911: HP:0002373 Febrile seizures
|
|
GS206355: GO:0023052 signaling
|
|
GS125402: Diethylnitrosamine interacting genes (MeSH:D004052) in CTD
|
|
GS181405: GO:0034702 ion channel complex
|
|
GS165524: MP:0010769 abnormal survival
|
|
GS187147: GO:0008076 voltage-gated potassium channel complex
|
|
GS33979: Cerebellum Gene expression correlates of Morphine distance (cm) travelled minutes 30-45 in Females & Males BXD
|
|
GS135725: duration of locomotor activity 1 (Dloc1, Published QTL Chr 2)
|
|
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
|
|
GS195977: GO:0007154 cell communication
|
|
GS126248: Acrylamide interacting genes (MeSH:D020106) in CTD
|
|
GS165243: MP:0010770 preweaning lethality
|
|
GS169393: MP:0002064 seizures
|
|
GS188947: GO:0022832 voltage-gated channel activity
|
|
GS205691: GO:0022008 neurogenesis
|
|
GS136338: nicotine induced locomotor activity 3 (Nilac3, Published QTL Chr 2)
|
|
GS203031: GO:0043194 axon initial segment
|
|
GS198214: GO:0022892 substrate-specific transporter activity
|
|
GS182469: GO:0043234 protein complex
|
|
GS190124: GO:0042592 homeostatic process
|
|
GS180164: GO:0008150 biological_process
|
|
GS183821: GO:0022843 voltage-gated cation channel activity
|
|
GS181404: GO:0034705 potassium channel complex
|
|
GS164004: MP:0011101 partial prenatal lethality
|
|
GS201111: GO:0005244 voltage-gated ion channel activity
|
|
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS177721: GO:0051234 establishment of localization
|
|
GS164262: MP:0002080 prenatal lethality
|
|
GS208482: GO:0042995 cell projection
|
|
GS165465: MP:0003633 abnormal nervous system physiology
|
|
GS181708: GO:0050801 ion homeostasis
|
|
GS86875: Table S2: Genes regulated in the VTA of Clock mutant mice Genes down-regulated in the VTA of Clock mutant mice vs littermate controls [DRG]
provisional
|
|
GS175187: HP:0002069 Generalized tonic-clonic seizures
|
|
GS165366: MP:0002272 abnormal nervous system electrophysiology
|
|
GS34482: Whole Brain Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery in BXD Males
|
|
GS204996: GO:0048858 cell projection morphogenesis
|
|
GS201949: GO:0044699 single-organism process
|
|
GS190397: GO:0032879 regulation of localization
|
|
GS188641: GO:0071944 cell periphery
|
|
GS209569: GO:0048667 cell morphogenesis involved in neuron differentiation
|
|
GS178461: GO:0009987 cellular process
|
|
GS195230: GO:0015077 monovalent inorganic cation transmembrane transporter activity
|
|
GS167630: MP:0000947 convulsive seizures
|
|
GS179402: GO:0005216 ion channel activity
|
|
GS34912: Striatum Gene expression correlates of Open Field - Total distance traveled 0-5 minutes in Males BXD
|
|
GS193268: GO:0005575 cellular_component
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS84142: alcohol preference locus (Published QTL, Chr 2)
|
|
GS135377: body length QTL 7 (Bdlnq7, Published QTL Chr 2)
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS170819: HP:0011153 Focal motor seizures
|
|
GS34946: Striatum Gene expression correlates of Open Field - Total distance traveled 15-20 minutes in Males BXD
|
|
GS84141: voluntary alcohol consumption QTL 1 (Vacq1, Published QTL, Chr 2)
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS190713: GO:0016021 integral to membrane
|
|
GS35467: Striatum Gene expression correlates of Left adrenal weight in Females & Males BXD
|
|
GS201989: GO:0005267 potassium channel activity
|
|
GS84138: METH responses for climbing (Published QTL, Chr 2)
|
|
GS210237: GO:0000902 cell morphogenesis
|
|
GS834: SeyPax6_Add_Down_Para
|
|
GS191106: GO:0044464 cell part
|
|
GS195770: GO:0015672 monovalent inorganic cation transport
|
|
GS192669: GO:0055082 cellular chemical homeostasis
|
|
GS210233: GO:0015079 potassium ion transmembrane transporter activity
|
|
GS135767: experimental allergic encephalomyelitis susceptibility 8 (Eae8, Published QTL Chr 2)
|
|
GS34922: Striatum Gene expression correlates of Open Field - Total distance traveled 10-15 minutes in Males BXD
|
|
GS171453: HP:0003674 Onset
|
|
GS168579: MP:0003635 abnormal synaptic transmission
|
|
GS177500: GO:0033268 node of Ranvier
|
|
GS177499: GO:0033267 axon part
|
|
GS192506: GO:0006813 potassium ion transport
|
|
GS129170: prion disease incubation time 2 (Prdt2 Published QTL Chr 2)
|
|
GS168502: MP:0002058 neonatal lethality
|
|
GS167565: MP:0001177 atelectasis
|
|
GS169020: MP:0001650 abnormal seizure response to electrical stimulation
|
|
GS135378: bone density traits 1 (Bdt1, Published QTL Chr 2)
|
|
GS180156: GO:0065008 regulation of biological quality
|
|
GS189484: GO:0023052 signaling
|
|
GS1140: Differential expression in brain of 22TNJ, a high alcohol-induced locomotor activation mutant
|
|
GS202715: GO:0035637 multicellular organismal signaling
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS33886: Cerebellum Gene expression correlates of Distance traveled (cm) during the first five minutes after ethanol in Males BXD
|
|
GS135281: "alcohol preference locus 5, male specific" (Alcp5, Published QTL Chr 2)
|
|
GS180228: GO:0005887 integral to plasma membrane
|
|
GS205812: GO:0022836 gated channel activity
|
|
GS194613: GO:0008092 cytoskeletal protein binding
|
|
GS177749: GO:0071804 cellular potassium ion transport
|
|
GS180142: GO:0048878 chemical homeostasis
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS187747: GO:0019226 transmission of nerve impulse
|
|
GS199199: GO:0031226 intrinsic to plasma membrane
|
|
GS163803: MP:0003631 nervous system phenotype
|